In addition, accumulating research showed that MDSCs have potent mechanisms to promote cancer growth (via downregulation of IFN-γ and expression of MMP9) and metastasis (via TNFα, TGFβ, CXCL2 and S100A8/9) by establishing an immunotolerant environment (240). The gene discussed is CXCL2; the disease is cancer.